Regulation of neuroinflammation by herbal medicine and its implications for neurodegenerative diseases: A focus on traditional medicines and flavonoids

NeuroSignals

Volumn 14, Issue 1-2, 2005, Pages 23-33

  Suk, Kyoungho ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Astrocyte; Central nervous system; Flavonoid; Inflammation; Microglia; Neurodegenerative disease; Neuroglia; Neuroprotection

Indexed keywords

ANGELICA PUBESCENS EXTRACT; FLAVONOID; GALANTAMINE; LEDEBOURIELLA DIVARICATA EXTRACT; LIGUSTICUM CHUANXIONG EXTRACT; MORUS ALBA EXTRACT; PLANT EXTRACT; SALVIA MILTIORRHIZA EXTRACT; SCUTELLARIA BAICALENSIS EXTRACT; UNCARIA RHYNCHOPHYLLA EXTRACT; UNCLASSIFIED DRUG; WOGONIN;

ANGELICA; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ASTROCYTE; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DRUG ACTIVITY; GENOMICS; GLIA; HERBAL MEDICINE; HIGH THROUGHPUT SCREENING; INFLAMMATION; LIGUSTICUM; MICROGLIA; MULBERRY; NEUROPROTECTION; NONHUMAN; PROTEOMICS; REVIEW; SALVIA MILTIORRHIZA; SCUTELLARIA BAICALENSIS; STROKE; TISSUE INJURY; UNCARIA;

ANIMALS; ASTROCYTES; ENCEPHALITIS; FLAVONOIDS; GLIOSIS; HUMANS; MEDICINE, HERBAL; MICROGLIA; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; PLANT PREPARATIONS;

EID: 20944431959     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085383     Document Type: Review

References (96)

1. Gehrmann J, Matsumoto Y, Kreutzberg GW: Microglia: Intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev 1995;20:269-287.
2. Gremo F, Sogos V, Ennas MG, Meloni A, Persichini T, Colasanti M, Lauro GM: Features and functions of human microglia cells. Adv Exp Med Biol 1997;429:79-97.
3. Stoll G, Jander S: The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol 1999;58:233-247.
4. Streit WJ, Walter SA, Pennell NA: Reactive microgliosis. Prog Neurobiol 1999;57:563-581.
5. Kreutzberg GW: Microglia: A sensor for pathological events in the CNS. Trends Neurosci 1996;19:312-318.
6. Minghetti L, Levi G: Microglia as effector cells in brain damage and repair: Focus on prostanoids and nitric oxide. Prog Neurobiol 1998;54:99-125.
7. Gonzalez-Scarano F, Baltuch G: Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 1999;22:219-240.
8. Araque A, Perea G: Glial modulation of synaptic transmission in culture. Glia 2004;47:241-248.
9. Vesce S, Bezzi P, Volterra A: The active role of astrocytes in synaptic transmission. Cell Mol Life Sci 1999;56:991-1000.
10. Aschner M: Astrocytes as mediators of immune and inflammatory responses in the CNS. Neurotoxicology 1998;19:269-281.
11. Galea E, Feinstein DL, Reis DJ: Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc Natl Acad Sci USA 1992;89:10945-10949.
12. Sawada M, Kondo N, Suzumura A, Marunouchi T: Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res 1989;491:394-397.
13. Simmons ML, Murphy S: Induction of nitric oxide synthase in glial cells. J Neurochem 1992;59:897-905.
14. Becher B, Prat A, Antel JP: Brain-immune connection: Immunoregulatory properties of CNS-resident cells. Glia 2000;29:293-304.
15. Nakamura Y: Regulating factors for microglial activation. Biol Pharm Bull 2002;25:945-953.
16. Ho LJ, Lai JH: Chinese herbs as immunomodulators and potential disease-modifying antirheumatic drugs in autoimmune disorders. Curr Drug Metab 2004;5:181-192.
17. Li FQ, Lu XZ, Liang XB, Zhou HF, Xue B, Liu XY, Niu DB, Han JS, Wang XM: Triptolide, a Chinese herbal extract, protects dopaminergic neurons from inflammation-mediated damage through inhibition of microglial activation. J Neuroimmunol 2004;148:24-31.
18. Ward PA, Warren JS, Johnson KJ: Oxygen radicals, inflammation, and tissue injury. Free Radic Biol Med 1988;5:403-408.
19. Henson PM, Johnston RB Jr: Tissue injury in inflammation: Oxidants, proteinases, and cationic proteins. J Clin Invest 1987;79:669-674.
20. Rankin JA: Biological mediators of acute inflammation. AACN Clin Issues 2004;15:3-17.
21. Halliwell B: Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann Rheum Dis 1995;54:505-510.
22. Nakajima K, Kohsaka S: Microglia: Activation and their significance in the central nervous system. J Biochem (Tokyo) 2001;130:169-175.
23. Liu B, Hong JS: Role of microglia in inflammation-mediated neurodegenerative diseases: Mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 2003;304:1-7.
24. Chavarria A, Alcocer-Varela J: Is damage in central nervous system due to inflammation? Autoimmun Rev 2004;3:251-260.
25. Popovich PG, Jones TB: Manipulating neuro-inflammatory reactions in the injured spinal cord: Back to basics. Trends Pharmacol Sci 2003;24:13-17.
26. von Knethen A, Lotero A, Brune B: Etoposide and cisplatin induced apoptosis in activated RAW 264.7 macrophages is attenuated by cAMP-induced gene expression. Oncogene 1998;17:387-394.
27. Albina JE, Cui S, Mateo RB, Reichner JS: Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 1993;150:5080-5085.
28. Adler B, Adler H, Jungi TW, Peterhans E: Interferon-alpha primes macrophages for lipopolysaccharide-induced apoptosis. Biochem Biophys Res Commun 1995;215:921-927.
29. Liu B, Wang K, Gao HM, Mandavilli B, Wang JY, Hong JS: Molecular consequences of activated microglia in the brain: Overactivation induces apoptosis. J Neurochem 2001;77:182-189.
30. Lee P, Lee J, Kim S, Yagita H, Lee MS, Kim SY, Kim H, Suk K: NO as an autocrine mediator in the apoptosis of activated microglial cells: Correlation between activation and apoptosis of microglial cells. Brain Res 2001;892:380-385.
31. Suk K, Lee J, Hur J, Kim YS, Lee MS, Cha SH, Kim SY, Kim H: Activation-induced cell death of rat astrocytes. Brain Res 2001;900:342-347.
32. Donjerkovic D, Scott DW: Activation-induced cell death in B lymphocytes [In Process Citation]. Cell Res 2000;10:179-192.
33. Crispe IN: Death and destruction of activated T lymphocytes. Immunol Res 1999;19:143-157.
34. Kingham PJ, Cuzner ML, Pocock JM: Apoptotic pathways mobilized in microglia and neurones as a consequence of chromogranin A-induced microglial activation. J Neurochem 1999;73:538-547.
35. Kingham PJ, Pocock JM: Microglial apoptosis induced by chromogranin A is mediated by mitochondrial depolarisation and the permeability transition but not by cytochrome c release. J Neurochem 2000;74:1452-1462.
36. Yang MS, Park EJ, Sohn S, Kwon HJ, Shin WH, Pyo HK, Jin B, Choi KS, Jou I, Joe EH: Interleukin-13 and -4 induce death of activated microglia. Glia 2002;38:273-280.
37. Takano K, Nakamura Y, Yoneda Y: Microglial cell death induced by a low concentration of polyamines. Neuroscience 2003;120:961-967.
38. Lee J, Hur J, Lee P, Kim JY, Cho N, Lee MS, Kim SY, Kim H, Suk K: Dual role of inflammatory stimuli in activation-induced cell death of mouse microglial cells: initiation of two separate apoptotic pathways via induction of interferon regulatory factor-1 and caspase-11. J Biol Chem 2001;276:32956- 32965.
39. Lee H, Cha S, Lee MS, Cho GJ, Choi WS, Suk K: Role of antiproliferative B cell translocation gene-1 as an apoptotic sensitizer in activation-induced cell death of brain microglia. J Immunol 2003;171:5802-5811.
40. Suk K, Kim SY, Kim H: Essential role of caspase-11 in activation-induced cell death of rat astrocytes. J Neurochem 2002;80:230-238.
41. Drache B, Diehl GE, Beyreuther K, Perlmutter LS, Konig G: Bcl-xl-specific antibody labels activated microglia associated with Alzheimer's disease and other pathological states. J Neurosci Res 1997;47:98-108.
42. Migheli A, Cavalla P, Piva R, Giordana MT, Schiffer D: bcl-2 protein expression in aged brain and neurodegenerative diseases. Neuroreport 1994;5:1906-1908.
43. Streit WJ: Microglia and Alzheimer's disease pathogenesis. J Neurosci Res 2004;77:1-8.
44. Giulian D: Ameboid microglia as effectors of inflammation in the central nervous system. J Neurosci Res 1987;18:155-171, 132-153.
45. Giulian D, Haverkamp LJ, Li J, Karshin WL, Yu J, Tom D, Li X, Kirkpatrick JB: Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem Int 1995;27:119-137.
46. Nagata K, Takei N, Nakajima K, Saito H, Kohsaka S: Microglial conditioned medium promotes survival and development of cultured mesencephalic neurons from embryonic rat brain. J Neurosci Res 1993;34:357-363.
47. McGeer PL, McGeer EG: The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 1995;21:195-218.
48. McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG: Microglia in degenerative neurological disease. Glia 1993;7:84-92.
49. Hanisch UK: Microglia as a source and target of cytokines. Glia 2002;40:140-155.
50. Bent S, Ko R: Commonly used herbal medicines in the United States: A review. Am J Med 2004;116:478-485.
51. De Smet PA: Herbal remedies. N Engl J Med 2002;347:2046-2056.
52. Gong X, Sucher NJ: Stroke therapy in traditional Chinese medicine (TCM): Prospects for drug discovery and development. Trends Pharmacol Sci 1999;20:191-196.
53. Howes MJ, Houghton PJ: Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol Biochem Behav 2003;75:513-527.
54. Chalela JA, Merino JG, Warach S: Update on stroke. Curr Opin Neurol 2004;17:447-451.
55. Harvey AL: Medicines from nature: Are natural products still relevant to drug discovery? Trends Pharmacol Sci 1999;20:196-198.
56. Kim YO, Leem K, Park J, Lee P, Ahn DK, Lee BC, Park HK, Suk K, Kim SY, Kim H: Cytoprotective effect of Scutellaria baicalensis in CA1 hippocampal neurons of rats after global cerebral ischemia. J Ethnopharmacol 2001;77:183-188.
57. Suk K, Kim SY, Leem K, Kim YO, Park SY, Hur J, Baek J, Lee KJ, Zheng HZ, Kim H: Neuroprotection by methanol extract of Uncaria rhynchophylla against global cerebral ischemia in rats. Life Sci 2002;70:2467-2480.
58. Kubo M, Matsuda H, Tanaka M, Kimura Y, Okuda H, Higashino M, Tani T, Namba K, Arichi S: Studies on Scutellariae radix. VII. Anti-arthritic and anti-inflammatory actions of methanolic extract and flavonoid components from Scutellariae radix. Chem Pharm Bull (Tokyo) 1984;32:2724-2729.
59. Sekiya K, Okuda H: Selective inhibition of platelet lipoxygenase by baicalein. Biochem Biophys Res Commun 1982;105:1090-1095.
60. Wakabayashi I: Inhibitory effects of baicalein and wogonin on lipopolysaccharide-induced nitric oxide production in macrophages. Pharmacol Toxicol 1999;84:288-291.
61. Gertz HJ, Kiefer M: Review about Ginkgo biloba special extract EGb 761 (Ginkgo). Curr Pharm Des 2004;10:261-264.
62. Bastianetto S, Ramassamy C, Dore S, Christen Y, Poirier J, Quirion R: The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid. Eur J Neurosci 2000;12:1882-1890.
63. Bastianetto S, Zheng WH, Quirion R: The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: Involvement of its flavonoid constituents and protein kinase C. J Neurochem 2000;74:2268-2277.
64. Braquet P, Hosford D: Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents. J Ethnopharmacol 1991;32:135-139.
65. Oyama Y, Chikahisa L, Ueha T, Kanemaru K, Noda K: Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Res 1996;712:349-352.
66. Beecher GR: Overview of dietary flavonoids: Nomenclature, occurrence and intake. J Nutr 2003;133:3248S-3254S.
67. Middleton E, Jr., Kandaswami C, Theoharides TC: The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000;52:673-751.
68. Middleton E Jr, Kandaswami C: Effects of flavonoids on immune and inflammatory cell functions. Biochem Pharmacol 1992;43:1167-1179.
69. Kim HK, Cheon BS, Kim YH, Kim SY, Kim HP: Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem Pharmacol 1999;58:759-765.
70. Wakabayashi I, Yasui K: Wogonin inhibits inducible prostaglandin E(2) production in macrophages [In Process Citation]. Eur J Pharmacol 2000;406:477-481.
71. Chang YL, Shen JJ, Wung BS, Cheng JJ, Wang DL: Chinese herbal remedy wogonin inhibits monocyte chemotactic protein-1 gene expression in human endothelial cells. Mol Pharmacol 2001;60:507-513.
72. Park BK, Heo MY, Park H, Kim HP: Inhibition of TPA-induced cyclooxygenase-2 expression and skin inflammation in mice by wogonin, a plant flavone from Scutellaria radix. Eur J Pharmacol 2001;425:153-157.
73. Gao Z, Huang K, Yang X, Xu H: Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochim Biophys Acta 1999;1472:643-650.
74. Shieh DE, Liu LT, Lin CC: Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin [In Process Citation]. Anticancer Res 2000;20:2861-2865.
75. Kandaswami C, Middleton E Jr: Free radical scavenging and antioxidant activity of plant flavonoids. Adv Exp Med Biol 1994;366:351-376.
76. Gao Z, Huang K, Xu H: Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxidative stress in HS-SY5Y cells. Pharmacol Res 2001;43:173-178.
77. Kim H, Kim YS, Kim SY, Suk K: The plant flavonoid wogonin suppresses death of activated C6 rat glial cells by inhibiting nitric oxide production. Neurosci Lett 2001;309:67-71.
78. Lee H, Kim YO, Kim SY, Kim H, Noh HS, Kang SS, Cho GJ, Choi WS, Suk K: Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J 2003;17:1943-1944.
79. Hamada H, Hiramatsu M, Edamatsu R, Mori A: Free radical scavenging action of baicalein. Arch Biochem Biophys 1993;306:261-266.
80. Suk K, Lee H, Kang SS, Cho GJ, Choi WS: Flavonoid baicalein attenuates activation-induced cell death of brain microglia. J Pharmacol Exp Ther 2003;305:638-645.
81. Boehm U, Klamp T, Groot M, Howard JC: Cellular responses to interferon-gamma. Annu Rev Immunol 1997;15:749-795.
82. Zhang ZJ: Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sci 2004;75:1659-1699.
83. Chopin P, Briley M: Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats. Psychopharmacology (Berl) 1992;106:26-30.
84. Woodruff-Pak DS, Vogel RW 3rd, Wenk GL: Galantamine: Effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning. Proc Natl Acad Sci USA 2001;98:2089-2094.
85. Sweeney JE, Bachman ES, Coyle JT: Effects of different doses of galanthamine, a long-acting acetylcholinesterase inhibitor, on memory in mice. Psychopharmacology (Berl) 1990;102:191-200.
86. Ha JH, Shin SM, Lee SK, Kim JS, Shin US, Huh K, Kim JA, Yong CS, Lee NJ, Lee DU: In vitro effects of hydroxybenzaldehydes from Gastrodia elata and their analogues on GABAergic neurotransmission, and a structure-activity correlation. Planta Med 2001;67:877-880.
87. Kim HJ, Moon KD, Lee DS, Lee SH: Ethyl ether fraction of Gastrodia elata Blume protects amyloid beta peptide-induced cell death. J Ethnopharmacol 2003;84:95-98.
88. Kim HJ, Lee SR, Moon KD: Ether fraction of methanol extracts of Gastrodia elata, medicinal herb protects against neuronal cell damage after transient global ischemia in gerbils. Phytother Res 2003;17:909-912.
89. Zangara A: The psychopharmacology of huperzine A: An alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease. Pharmacol Biochem Behav 2003;75:675-686.
90. Wen TC, Yoshimura H, Matsuda S, Lim JH, Sakanaka M: Ginseng root prevents learning disability and neuronal loss in gerbils with 5-minute forebrain ischemia. Acta Neuropathol (Berl) 1996;91:15-22.
91. Lim JH, Wen TC, Matsuda S, Tanaka J, Maeda N, Peng H, Aburaya J, Ishihara K, Sakanaka M: Protection of ischemic hippocampal neurons by ginsenoside Rb1, a main ingredient of ginseng root. Neurosci Res 1997;28:191-200.
92. Kennedy DO, Scholey AB: Ginseng: Potential for the enhancement of cognitive performance and mood. Pharmacol Biochem Behav 2003;75:687-700.
93. Fahn S, Cohen G: The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it. Ann Neurol 1992;32:804-812.
94. Metodiewa D, Koska C: Reactive oxygen species and reactive nitrogen species: Relevance to cyto(neuro)toxic events and neurologic disorders: An overview. Neurotox Res 2000;1:197-233.
95. Ahlemeyer B, Krieglstein J: Neuroprotective effects of Ginkgo biloba extract. Cell Mol Life Sci 2003;60:1779-1792.
96. Rahman K: Garlic and aging: New insights into an old remedy. Ageing Res Rev 2003;2:39-56.